93 related articles for article (PubMed ID: 2881445)
1. Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
Agid Y; Javoy-Agid F; Ruberg M; Pillon B; Dubois B; Duyckaerts C; Hauw JJ; Baron JC; Scatton B
Adv Neurol; 1987; 45():191-206. PubMed ID: 2881445
[No Abstract] [Full Text] [Related]
2. Progressive supranuclear palsy: postmortem chemical analysis.
Young AB
Ann Neurol; 1985 Nov; 18(5):521-2. PubMed ID: 2866753
[No Abstract] [Full Text] [Related]
3. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Kish SJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
[TBL] [Abstract][Full Text] [Related]
4. Aging and neurotransmitter systems.
McGeer EG; McGeer PL
Adv Biochem Psychopharmacol; 1980; 23():305-14. PubMed ID: 6104910
[No Abstract] [Full Text] [Related]
5. Neurotransmitter receptor binding: regional distribution in human brain.
Enna SJ; Bennett JP; Bylund DB; Creese I; Burt DR; Charness ME; Yamamura HI; Simantov R; Snyder SH
J Neurochem; 1977 Jan; 28(1):233-6. PubMed ID: 13155
[No Abstract] [Full Text] [Related]
6. Anterior cingulate dysfunction in presenile dementia due to progressive supranuclear palsy.
Salmon E; Meulemans T; van der Linden M; Degueldre C; Franck G
Acta Neurol Belg; 1996 Sep; 96(3):247-53. PubMed ID: 8886112
[TBL] [Abstract][Full Text] [Related]
7. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
[No Abstract] [Full Text] [Related]
8. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.
Boeve BF; Lang AE; Litvan I
Ann Neurol; 2003; 54 Suppl 5():S15-9. PubMed ID: 12833363
[No Abstract] [Full Text] [Related]
9. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
[TBL] [Abstract][Full Text] [Related]
10. An update on the neurochemistry of Alzheimer disease.
Davies P
Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
[No Abstract] [Full Text] [Related]
11. [Modifications in neurotransmission in degenerative dementia].
Maloteaux JM
Acta Neurol Belg; 1989; 89(3-4):186-93. PubMed ID: 2576495
[No Abstract] [Full Text] [Related]
12. Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
Li F; Iseki E; Kosaka K; Nishimura T; Akiyama H; Kato M
Clin Neuropathol; 1996; 15(6):319-23. PubMed ID: 8937777
[TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia.
Oide T; Ohara S; Yazawa M; Inoue K; Itoh N; Tokuda T; Ikeda S
Acta Neuropathol; 2002 Aug; 104(2):209-14. PubMed ID: 12111365
[TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
Reisine TD; Yamamura HI; Bird ED; Spokes E; Enna SJ
Brain Res; 1978 Dec; 159(2):477-81. PubMed ID: 215272
[No Abstract] [Full Text] [Related]
15. Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease.
Singer HS; Coyle JT; Weaver DL; Kawamura N; Baker HJ
Ann Neurol; 1982 Jul; 12(1):37-41. PubMed ID: 6126152
[TBL] [Abstract][Full Text] [Related]
16. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.
Armstrong RA; Lantos PL; Cairns NJ
Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313
[TBL] [Abstract][Full Text] [Related]
17. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
[TBL] [Abstract][Full Text] [Related]
18. Hypertension and progressive supranuclear palsy: is everything so clear?
Sibon I; Macia F; Vital A; Delacourte A; Tison F
Mov Disord; 2004 Oct; 19(10):1259-61. PubMed ID: 15390036
[No Abstract] [Full Text] [Related]
19. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
Kasashima S; Oda Y
Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter receptor alterations in Parkinson's disease.
Reisine TD; Fields JZ; Yamamura HI
Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
